Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations

Documenti analoghi

• Cystathionine as a Potential Urinary Marker for Diagnosing and Assessing Pretreatment Risk in Neuroblastoma
  di: Hizuru Amano, et al.
  Pubblicazione: (2025)
• Response to the Comment on “Long‐Term Outcomes of Congenital Biliary Dilatation Surgery: A Single‐Center Study Highlighting the High Incidence of Complications Within 5 Years”
  di: Takuya Maeda, et al.
  Pubblicazione: (2026)
• The First Case of Bile Duct Resection Using the da Vinci SP for Congenital Biliary Dilatation in an Infant
  di: Satoshi Makita, et al.
  Pubblicazione: (2026)
• Characteristics and outcomes of minimally invasive surgery for congenital biliary dilatation in children aged <6 years: Comparison between children and adults
  di: Yoichi Nakagawa, et al.
  Pubblicazione: (2024)
• Effect of General Anesthesia on Liver and Spleen Stiffness for Predicting High‐Risk Varices in Biliary Atresia
  di: Shinya Yokoyama, et al.
  Pubblicazione: (2025)